Peptide · Research-only
Dihexa
A highly experimental compound claimed to boost cognition, with almost no human data. Unapproved.
Key facts
- Status: Research-only
- Used for: Cognition (experimental)
- Natural counterpart: A derivative of natural angiotensin IV.
- Target enzyme / receptor: Hepatocyte growth factor (HGF) / c-Met pathway (proposed)
- Signalling pathway: Claimed promotion of synaptogenesis (experimental, unverified in humans)
In plain terms: Claimed to build new synaptic connections — experimental. - Crystal structure: no peptide–target complex in the PDB yet — study the target ↗
Status & safety
This is sold as an unapproved “research chemical” (labelled “not for human use”). It is not approved, is unregulated, and carries real safety and legal risks. We cover it for information, not to encourage buying or using it.
Research & clinical studies
Explore the biochemistry and clinical evidence for Dihexa — these open live, date-sorted searches, so they always show the latest.
Read research papers on PubMed ↗
Clinical studies (ClinicalTrials.gov) ↗
Google Scholar ↗
Related guide →
All peptides & profiles →
Not medical advice. Chemdu is an educational resource and does not sell, prescribe or supply any peptide. Consult a licensed professional about any medicine or supplement.